{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:58:04Z","timestamp":1793429884537,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aimed to systematically investigate the efficacy of adipose-derived stem cells (ASCs) in complex anal fistula treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study systematically searched randomized controlled studies on the efficacy of ASCs in treating complex anal fistula published before June 2024 in PubMed, EMBASE, Web of Science, and Cochrane Library. Further, relevant journals were manually searched for relevant references, and two researchers independently performed literature search and screening, data extraction, and bias assessment. Stata version 12.0 was utilized to statistically analyze the healing rate of the anal fistula and the incidence of adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study involved 1,056 patients from five randomized controlled trials, including 561 patients in the treatment group (ASCs\/ASCs + fibrin glue) and 495 patients in the control group (fibrin glue\/placebo). Meta-analysis revealed better short- and long-term efficacy of adipose mesenchymal stem cell treatment for complex perianal fistulas than in conventional treatment. However, no statistical difference was observed between mid-term and ultra-long-term treatments. Subgroup meta-analysis demonstrated a difference in efficacy between various cell doses. Further, all treatments with different sources of ASCs were superior to conventional quality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study confirms that Adipose-derived Stem Cells can effectively improve short-term and long-term (1-year) clinical outcomes in patients with complex perianal fistulas, supporting their potential as a novel therapeutic strategy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024602327<\/jats:uri>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1627065","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T14:19:34Z","timestamp":1756217974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Adipose-derived stem cell therapies for complex anal fistula: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"12","author":[{"given":"Meng","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s13304-013-0216-1","article-title":"Fistulotomy or seton in anal fistula: a decisional algorithm","volume":"65","author":"Cariati","year":"2013","journal-title":"Updat Surg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/bjs.1800820711","article-title":"Seton treatment of perianal fistula with high anal or rectal opening","volume":"82","author":"Van Tets","year":"1995","journal-title":"Br J Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/CEG.S198796","article-title":"Management of Complex Cryptoglandular Anal Fistula: challenges and solutions","volume":"13","author":"Garg","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cps.2014.12.007","article-title":"Adipose stem cells: biology, safety, regulation, and regenerative potential","volume":"42","author":"Minteer","year":"2015","journal-title":"Clin Plast Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00005-016-0394-x","article-title":"Adipose-derived stem cells as a tool in cell-based therapies","volume":"64","author":"Bajek","year":"2016","journal-title":"Arch Immunol Ther Exp"},{"key":"ref6","first-page":"566","article-title":"Clinical research of autologous adipose-derived stem cell transplantation in the treatment of complex anal fistulas","volume":"8","author":"Jiang","year":"2019","journal-title":"Chin J Colorectal Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00604-025-07369-6","article-title":"Comparative study on biological characteristics of mesenchymal stem cells from human umbilical cord and adipose","volume":"56","author":"Huang","year":"2018","journal-title":"J Shandong Univ"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13287-023-03331-6","article-title":"Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials","volume":"14","author":"Wang","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l5399","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/DCR.0b013e318255364a","article-title":"Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula advanced therapy trial 1) and long-term evaluation","volume":"55","author":"Herreros","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/sctm.19-0271","article-title":"Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up","volume":"9","author":"Garcia-Arranz","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/ecco-jcc\/jjx002.008","article-title":"Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trial","volume":"11","author":"Panes","year":"2017","journal-title":"J Crohn's Colitis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S327","DOI":"10.1093\/ecco-jcc\/jjy222.560","article-title":"Darvadstrocel treatment outcomes in Crohn's disease patients with complex perianal fistulas: the role of TNFi co-treatment in ADMIRE CD","volume":"13","author":"Pan\u00e9s","year":"2019","journal-title":"J Crohn's Colitis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10151-020-02193","article-title":"Stem cell therapy (darvadstrocel) for treatment-refractory complex perianal fistulas in patients with crohn's disease: 2-year efficacy and safety data","volume":"24","author":"Spinelli","year":"2020","journal-title":"Tech Coloproctol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up study to evaluate the long-term safety and efficacy of Darvadstrocel (mesenchymal stem cell treatment) in patients with perianal Fistulizing Crohn\u2019s disease: ADMIRE-CD phase 3 randomized controlled trial","volume":"65","author":"Garcia-Olmo","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S-181","DOI":"10.1016\/S0016-5085(24)00912-0","article-title":"761 efficacy and safety of DARVADSTROCEL treatment in patients with complex perianal fistulas and CROHN'S disease: results from the global admire-cd ii phase 3 study","volume":"166","author":"Serclova","year":"2024","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/bjs.1800781004","article-title":"Seton treatment of high anal fistulae","volume":"78","author":"Williams","year":"1991","journal-title":"Br J Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00266-020-01819-7","article-title":"Cell-assisted Lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem\/stromal cells","volume":"44","author":"Yoshimura","year":"2020","journal-title":"Aesth Plast Surg"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jcpa.2011.01.012","article-title":"Heterogeneity of macrophage populations and expression of galectin-3 in cutaneous wound healing in rats","volume":"145","author":"Pan\u00e9s","year":"2011","journal-title":"J Comp Pathol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/wrr.12173","article-title":"Role of adipose-derived stem cells in wound healing","volume":"22","author":"Hassan","year":"2014","journal-title":"Wound Repair Regen"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e86865","DOI":"10.1371\/journal.pone.0086865","article-title":"Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells","volume":"9","author":"Desai","year":"2014","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1089\/ten.tea.2009.0710","article-title":"Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers","volume":"16","author":"Park","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2013.00201","article-title":"Mesenchymal stem cells in tissue repair","volume":"4","author":"Dimarino","year":"2013","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1007\/s12015-022-10436-7","article-title":"BMSCs-derived mitochondria improve osteoarthritis by ameliorating mitochondrial dysfunction and promoting mitochondrial biogenesis in chondrocytes","volume":"18","author":"Yu","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1517\/14712598.2010.519333","article-title":"Mesenchymal stem cells: biological properties and clinical applications","volume":"10","author":"Garc\u00eda-G\u00f3mez","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.imlet.2015.06.007","article-title":"The secretome of mesenchymal stromal cells: role of extracellular vesicles in immunomodulation","volume":"168","author":"Bruno","year":"2015","journal-title":"Immunol Lett"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.exphem.2005.05.002","article-title":"Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells","volume":"33","author":"Groh","year":"2005","journal-title":"Exp Hematol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1089\/ten.2006.12.2263","article-title":"Human mesenchymal stem cells induce T cell anergy and downregulate T cell Allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves","volume":"12","author":"Batten","year":"2006","journal-title":"Tissue Eng"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","article-title":"Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn\u2019s disease: a new cell-based therapy","volume":"18","author":"Garc\u00eda-Olmo","year":"2003","journal-title":"Int J Color Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garc\u00eda-Olmo","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease","volume":"149","author":"Molendijk","year":"2015","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.athoracsur.2008.11.057","article-title":"Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage","volume":"87","author":"Hamamoto","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","article-title":"Crypt stem cells as the cells-of-origin of intestinal cancer","volume":"457","author":"Barker","year":"2009","journal-title":"Nature"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1627065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T14:19:35Z","timestamp":1756217975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1627065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":41,"alternative-id":["10.3389\/fmed.2025.1627065"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1627065","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"article-number":"1627065"}}